Explore more publications!
Tech Focus Asia
Got News to Share?

Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 6, 2025

Ainnocence Announces AI Platform for Material Performance Prediction and Process Optimization
December 6, 2025

Ainnocence Announces AI Platform for Material Performance Prediction and Process Optimization

Indeterminate EIN Presswire
Deep Learning Market Growth to Top USD 406 Billion by 2032 | CAGR Projected at 37.8%
December 6, 2025

Deep Learning Market Growth to Top USD 406 Billion by 2032 | CAGR Projected at 37.8%

Indeterminate EIN Presswire
Driving with 18.7% CAGR | Computer Vision Market Size Reach USD 82.1 Billion by 2032
December 6, 2025

Driving with 18.7% CAGR | Computer Vision Market Size Reach USD 82.1 Billion by 2032

Indeterminate EIN Presswire
Driving with 22.6% CAGR | IoT in Manufacturing Market Reach USD 1,495.65 Billion by 2030
December 6, 2025

Driving with 22.6% CAGR | IoT in Manufacturing Market Reach USD 1,495.65 Billion by 2030

Indeterminate EIN Presswire
Situation Awareness System Market Reach USD 67.27 Billion by 2030
December 6, 2025

Situation Awareness System Market Reach USD 67.27 Billion by 2030

Indeterminate EIN Presswire
Artificial Intelligence of Things (AIoT) Market Set to Hit $1.3 Trillion by 2032 | 30.2% CAGR
December 6, 2025

Artificial Intelligence of Things (AIoT) Market Set to Hit $1.3 Trillion by 2032 | 30.2% CAGR

Indeterminate EIN Presswire
Driving with 17.4% CAGR | Hybrid Cloud Market Share Reach USD 480.2 Billion by 2033
December 6, 2025

Driving with 17.4% CAGR | Hybrid Cloud Market Share Reach USD 480.2 Billion by 2033

Indeterminate EIN Presswire
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 6, 2025

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 6, 2025

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

Indeterminate GlobeNewswire
Sapu Nano 宣布推出基于 Deciparticle™ 技术的生物标志物框架，用于识别最可能对静脉注射 Sapu003（一种依维莫司纳米药物）产生反应的肿瘤
December 6, 2025

Sapu Nano 宣布推出基于 Deciparticle™ 技术的生物标志物框架，用于识别最可能对静脉注射 Sapu003（一种依维莫司纳米药物）产生反应的肿瘤

Indeterminate GlobeNewswire
Sapu Nano 宣佈由 Deciparticle™ 驅動的生物標記框架，可識別出最有可能對靜脈注射依維莫司納米藥物 Sapu003 產生反應的腫瘤
December 6, 2025

Sapu Nano 宣佈由 Deciparticle™ 驅動的生物標記框架，可識別出最有可能對靜脈注射依維莫司納米藥物 Sapu003 產生反應的腫瘤

Indeterminate GlobeNewswire
BioNTechs und OncoC4s selektiver Treg-Modulatorkandidat Gotistobart erzielte klinisch relevanten Gesamtüberlebensvorteil bei Patientinnen und Patienten mit zuvor behandeltem Plattenepithelkarzinom der Lunge
December 6, 2025

BioNTechs und OncoC4s selektiver Treg-Modulatorkandidat Gotistobart erzielte klinisch relevanten Gesamtüberlebensvorteil bei Patientinnen und Patienten mit zuvor behandeltem Plattenepithelkarzinom der Lunge

Indeterminate GlobeNewswire
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
December 6, 2025

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire
Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
December 6, 2025

Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness

Indeterminate GlobeNewswire
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
December 6, 2025

Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting

Indeterminate GlobeNewswire
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
December 6, 2025

Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025

Indeterminate GlobeNewswire
SaaS Market to Register Robust Growth | Competitive Trends & Opportunity Landscape
December 6, 2025

SaaS Market to Register Robust Growth | Competitive Trends & Opportunity Landscape

Indeterminate EIN Presswire
RadiantVibe Capital Consortium Debuts Insight Access Dashboard as Part of Ambrose Wetherby’s Transparency Initiative
December 6, 2025

RadiantVibe Capital Consortium Debuts Insight Access Dashboard as Part of Ambrose Wetherby’s Transparency Initiative

Indeterminate GlobeNewswire
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs
December 6, 2025

Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs

Indeterminate GlobeNewswire
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
December 6, 2025

Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions